Skip to content

Hybrid Stroke Rehab With Mirror Priming

Hybrid Stroke Rehabilitation With Mirror Priming

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07324278
Enrollment
81
Registered
2026-01-07
Start date
2026-02-02
Completion date
2030-12-31
Last updated
2026-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases, Cerebrovascular Disorders, Stroke

Keywords

Rehabilitation, Mirror Therapy

Brief summary

This trial aims to examine the effects of enhanced mirror priming, overcoming the limitations of traditional mirror therapy, to achieve optimization and personalized intervention.

Interventions

BEHAVIORALMirror priming

During the mirror priming process, the movement images of the participant's unaffected limb are mirrored to the affected side to provide visual feedback.

BEHAVIORALConventional therapy

Conventional therapy is individualized and may include impairment-oriented, shaping, or whole-task practice.

Sponsors

I-Shou University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. A first-ever unilateral stroke ≥3 months 2. Age between 20 and 80 years 3. Baseline Fugl-Meyer Assessment Upper Extremity (FMA-UE) score ≥ 10 4. No severe spasticity in any joints of the affected arm 5. Ability to follow the instructions 6. No participation in other studies during the study period 7. Willingness to provide informed written consent.

Exclusion criteria

1. Serious medical problems or poor physical conditions that might be detrimental to study participation. 2. Received or planned botulinum toxin injections within 3 months prior to or during the trial

Design outcomes

Primary

MeasureTime frame
Fugl-Meyer AssessmentBaseline, 2 weeks, 4 weeks, and 3 months post-intervention.

Secondary

MeasureTime frame
Grip and pinch powerBaseline, 4 weeks, and 3 months post-intervention.
Revised Nottingham Sensory AssessmentBaseline, 4 weeks, and 3 months post-intervention.
Berg Balance ScaleBaseline, 4 weeks, and 3 months post-intervention.
Motor Activity LogBaseline, 4 weeks, and 3 months post-intervention.
ABILHAND QuestionnaireBaseline, 4 weeks, and 3 months post-intervention.
Chedoke Arm and Hand Activity InventoryBaseline, 4 weeks, and 3 months post-intervention.
Stroke Impact ScaleBaseline, 4 weeks, and 3 months post-intervention.
Stroke Self-Efficacy QuestionnaireBaseline, 4 weeks, and 3 months post-intervention.

Countries

Taiwan

Contacts

CONTACTYi-chun Li, PhD
joyjoyfish@gmail.com+886-7-6151100

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 26, 2026